LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 42 filers reported holding LUMOS PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 117 | -33.5% | 0.00% | – |
| Q2 2023 | $0 | – | 176 | +252.0% | 0.00% | – |
| Q1 2023 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 50 | -80.2% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 252 | -39.0% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 413 | -0.5% | 0.00% | – |
| Q1 2022 | $4,000 | +100.0% | 415 | +91.2% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 217 | +1.9% | 0.00% | – |
| Q3 2021 | $2,000 | -33.3% | 213 | -15.1% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 251 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | 0.0% | 251 | +248.6% | 0.00% | – |
| Q4 2020 | $3,000 | +200.0% | 72 | +89.5% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 38 | -32.1% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 56 | -71.6% | 0.00% | – |
| Q1 2020 | $1,000 | – | 197 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 407,192 | $5,627,000 | 1.23% |
| Opaleye Management Inc. | 240,892 | $3,329,000 | 0.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 936,291 | $12,940,000 | 0.32% |
| NEA Management Company, LLC | 526,663 | $7,278,000 | 0.31% |
| Investors Financial Group, LLC | 21,766 | $301,000 | 0.22% |
| Wealth Advisors of Iowa, LLC | 11,760 | $163,000 | 0.11% |
| Blackstone Inc. | 468,145 | $6,470,000 | 0.02% |
| Jefferies Group LLC | 120,651 | $1,667,000 | 0.02% |
| Texas Yale Capital Corp. | 16,000 | $221,000 | 0.02% |
| Prospera Financial Services Inc | 1,088 | $15,000 | 0.01% |